FMR LLC 13D/13G Filings for Nektar Therapeutics (NKTR)

FMR LLC 13D and 13G filings for Nektar Therapeutics:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-02-09
09:22 am
Sale		 2022-02-08 13G Nektar Therapeutics
NKTR		 FMR LLC 6,759,203
3.662%		 -2,706,605decrease
(-28.59%)		 Filing
2021-12-10
08:52 am
Sale		 2021-12-09 13G Nektar Therapeutics
NKTR		 FMR LLC 9,465,808
5.128%		 -9,483,876decrease
(-50.05%)		 Filing
2021-02-08
10:29 am
Purchase		 2021-02-05 13G Nektar Therapeutics
NKTR		 FMR LLC 18,949,684
10.562%		 251,281increase
(+1.34%)		 Filing